213 related articles for article (PubMed ID: 37435257)
1. Second-Generation Parenteral Antipsychotic (Olanzapine) as a First-Line Treatment for Acute Undifferentiated Agitation in the Emergency Department in Comparison With Haloperidol.
Singh AP; Murali Mohan NT
Cureus; 2023 Jun; 15(6):e40226. PubMed ID: 37435257
[TBL] [Abstract][Full Text] [Related]
2. Parenteral Antipsychotic Choice and Its Association With Emergency Department Length of Stay for Acute Agitation Secondary to Alcohol Intoxication.
Cole JB; Klein LR; Martel ML
Acad Emerg Med; 2019 Jan; 26(1):79-84. PubMed ID: 29851193
[TBL] [Abstract][Full Text] [Related]
3. Prehospital Agitation and Sedation Trial (PhAST): A Randomized Control Trial of Intramuscular Haloperidol versus Intramuscular Midazolam for the Sedation of the Agitated or Violent Patient in the Prehospital Environment.
Isenberg DL; Jacobs D
Prehosp Disaster Med; 2015 Oct; 30(5):491-5. PubMed ID: 26323511
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of ketamine for initial control of acute agitation in the emergency department: A randomized study.
Lin J; Figuerado Y; Montgomery A; Lee J; Cannis M; Norton VC; Calvo R; Sikand H
Am J Emerg Med; 2021 Jun; 44():306-311. PubMed ID: 32340820
[TBL] [Abstract][Full Text] [Related]
5. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial.
Huang CL; Hwang TJ; Chen YH; Huang GH; Hsieh MH; Chen HH; Hwu HG
J Formos Med Assoc; 2015 May; 114(5):438-45. PubMed ID: 25791540
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of haloperidol plus lorazepam versus droperidol plus midazolam for the treatment of acute agitation in the emergency department.
Thiemann P; Roy D; Huecker M; Senn J; Javed J; Thomas A; Shreffler J; Shaw I
Am J Emerg Med; 2022 May; 55():76-81. PubMed ID: 35287091
[TBL] [Abstract][Full Text] [Related]
7. Intramuscular Midazolam, Olanzapine, Ziprasidone, or Haloperidol for Treating Acute Agitation in the Emergency Department.
Klein LR; Driver BE; Miner JR; Martel ML; Hessel M; Collins JD; Horton GB; Fagerstrom E; Satpathy R; Cole JB
Ann Emerg Med; 2018 Oct; 72(4):374-385. PubMed ID: 29885904
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological management of acute agitation.
Battaglia J
Drugs; 2005; 65(9):1207-22. PubMed ID: 15916448
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy.
Wright P; Meehan K; Birkett M; Lindborg SR; Taylor CC; Morris P; Breier A
Clin Ther; 2003 May; 25(5):1420-8. PubMed ID: 12867218
[TBL] [Abstract][Full Text] [Related]
10. The expert consensus guideline series. Treatment of behavioral emergencies 2005.
Allen MH; Currier GW; Carpenter D; Ross RW; Docherty JP;
J Psychiatr Pract; 2005 Nov; 11 Suppl 1():5-108; quiz 110-2. PubMed ID: 16319571
[TBL] [Abstract][Full Text] [Related]
11. A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation.
MacDonald K; Wilson M; Minassian A; Vilke GM; Becker O; Tallian K; Cobb P; Perez R; Galangue B; Feifel D
J Clin Psychopharmacol; 2012 Jun; 32(3):317-22. PubMed ID: 22544013
[TBL] [Abstract][Full Text] [Related]
12. Haloperidol plus promethazine for psychosis-induced aggression.
Huf G; Alexander J; Allen MH; Raveendran NS
Cochrane Database Syst Rev; 2009 Jul; (3):CD005146. PubMed ID: 19588366
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.
Breier A; Meehan K; Birkett M; David S; Ferchland I; Sutton V; Taylor CC; Palmer R; Dossenbach M; Kiesler G; Brook S; Wright P
Arch Gen Psychiatry; 2002 May; 59(5):441-8. PubMed ID: 11982448
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Midazolam Versus Haloperidol Versus Olanzapine for the Management of Acute Agitation in the Accident and Emergency Department.
Yan VKC; Haendler M; Lau H; Li X; Lao KSJ; Tsui SH; Yap CYL; Knapp MRJ; Chan EW
Value Health; 2022 Jul; 25(7):1099-1106. PubMed ID: 35151559
[TBL] [Abstract][Full Text] [Related]
15. Intramuscular midazolam, olanzapine, or haloperidol for the management of acute agitation: A multi-centre, double-blind, randomised clinical trial.
Chan EW; Lao KSJ; Lam L; Tsui SH; Lui CT; Wong CP; Graham CA; Cheng CH; Chung TS; Lam HF; Ting SM; Knott JC; Taylor DM; Kong DCM; Leung LP; Wong ICK
EClinicalMedicine; 2021 Feb; 32():100751. PubMed ID: 33681744
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous olanzapine for hyperactive or mixed delirium in patients with advanced cancer: a preliminary study.
Elsayem A; Bush SH; Munsell MF; Curry E; Calderon BB; Paraskevopoulos T; Fadul N; Bruera E
J Pain Symptom Manage; 2010 Nov; 40(5):774-82. PubMed ID: 20728301
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Droperidol and Midazolam Versus Haloperidol and Lorazepam for Acute Agitation Management in the Emergency Department.
Allen PJ; Johanson KE; Reveles KR; Neff LA; Lock AE
Ann Pharmacother; 2023 Dec; 57(12):1367-1374. PubMed ID: 36999520
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, randomized comparison study of efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in patients with schizophrenia and acute agitated behavior.
Chan HY; Ree SC; Su LW; Chen JJ; Chou SY; Chen CK; Chen YS
J Clin Psychopharmacol; 2014 Jun; 34(3):355-8. PubMed ID: 24743717
[TBL] [Abstract][Full Text] [Related]
19. Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine.
Raveendran NS; Tharyan P; Alexander J; Adams CE;
BMJ; 2007 Oct; 335(7625):865. PubMed ID: 17954514
[TBL] [Abstract][Full Text] [Related]
20. A retrospective analysis of intramuscular haloperidol and intramuscular olanzapine in the treatment of agitation in drug- and alcohol-using patients.
MacDonald K; Wilson MP; Minassian A; Vilke GM; Perez R; Cobb P; Tallian K; Becker O; Feifel D
Gen Hosp Psychiatry; 2010; 32(4):443-5. PubMed ID: 20633750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
